MSB 2.45% 99.5¢ mesoblast limited

Ann: Mesoblast to Evaluate Remestemcel-L in COVID-19 Lung Disease, page-6

  1. 716 Posts.
    lightbulb Created with Sketch. 35
    https://hotcopper.com.au/data/attachments/2033/2033203-c95a108b06861787ddda8246d5667a33.jpg
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.